***To keep it short and simple....as I have said, the ultimate pricing will determine the worth of the deal.***
The above was part of my reply to the long post by dis on the metrics of the LPC deal.
There appears to be wiggle room.
>>>This limitation will not apply if, at any time the Exchange Cap is reached and at all times thereafter, the average price paid for all shares issued and sold under the Purchase Agreement is equal to or greater than $1.6674<<<
Its been a long road for long time shareholders.
Events of 2017 crucial.
There has always been so much to be critical about here but this deal has been crafted that if the proverbial "broken clock" is right this time they can take advantage. The one word to remember is not "plastics" but "pricing" LOL !
Anyway, I thought I would throw this clarification into the discussion.
HF, likely a moot point since I believe the LP agreement was entered into for back-up insurance in case enough cash was not raised from partnership(s) in Q-1 and/or Q-2 - IMO, the LP deal will not be used!
Consider the roughly $200,000 commitment fee already paid in stock. That is a high price for something if it is not used. I agree with Hedge, the bulk of the shares put to LPC will be after the STAR data is released.
Cytori would be negligent if they weren't already tapping the LP equity line all year. They are low on cash and that is the worse position to be in when in partnership talks. Expect the lenders to take a pound of flesh too if Cytori need to renegotiate again.